Scribd Logo
Upload

Welcome to Scribd!

  • 159 views

    Glaxosmithkline: Read More Detailed History Here Link Link

    Uploaded by

    Soumya Halder
    GlaxoSmithKline is a global healthcare company headquartered in the UK. It has operations across pharmaceuticals, vaccines, and consumer healthcare. In India, GSK has a presence across pharmaceutical manufacturing, clinical development, and vaccine production. It has over 4,500 employees in India. Some of GSK's major brands include Calpol, Augmentin, Ceftum, and vaccines for hepatitis, influenza, diphtheria, and more. Its competitors in India include Sun Pharma, Lupin, Cipla, and Dr. Reddy's.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Glaxosmithkline: Read More Detailed History Here Link Link

    Uploaded by

    Soumya Halder
    159 views6 pages
    GlaxoSmithKline is a global healthcare company headquartered in the UK. It has operations across pharmaceuticals, vaccines, and consumer healthcare. In India, GSK has a presence across pharmaceutical manufacturing, clinical development, and vaccine production. It has over 4,500 employees in India. Some of GSK's major brands include Calpol, Augmentin, Ceftum, and vaccines for hepatitis, influenza, diphtheria, and more. Its competitors in India include Sun Pharma, Lupin, Cipla, and Dr. Reddy's.

    Original Description:

    Company Analysis

    Original Title

    GSK

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    GlaxoSmithKline is a global healthcare company headquartered in the UK. It has operations across pharmaceuticals, vaccines, and consumer healthcare. In India, GSK has a presence across pharmaceutical manufacturing, clinical development, and vaccine production. It has over 4,500 employees in India. Some of GSK's major brands include Calpol, Augmentin, Ceftum, and vaccines for hepatitis, influenza, diphtheria, and more. Its competitors in India include Sun Pharma, Lupin, Cipla, and Dr. Reddy's.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    159 views6 pages

    Glaxosmithkline: Read More Detailed History Here Link Link

    Uploaded by

    Soumya Halder
    GlaxoSmithKline is a global healthcare company headquartered in the UK. It has operations across pharmaceuticals, vaccines, and consumer healthcare. In India, GSK has a presence across pharmaceutical manufacturing, clinical development, and vaccine production. It has over 4,500 employees in India. Some of GSK's major brands include Calpol, Augmentin, Ceftum, and vaccines for hepatitis, influenza, diphtheria, and more. Its competitors in India include Sun Pharma, Lupin, Cipla, and Dr. Reddy's.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 6

    GlaxoSmithKline

    Do more, feel better, live longer

    History and Evolution 1924, Glaxo came to India as H J Foster & Co. | Parent Company GSK plc, UK, one of the world's leading research-
    based pharmaceutical & healthcare companies | Manufactures prescription medicines/ vaccines | Has operations
    across pharmaceuticals, vaccines and consumer health domains | GSK Global Headquarters: London, UK | GSK
    India headquarters: Mumbai, Maharashtra
    Read more Detailed History here
    Goal Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. Link
    Strategy Our strategy is to bring differentiated, high-quality and needed healthcare products to as many people as
    possible, with our three global businesses, scientific and technical know-how and talented people. Link
    Values & Expectations Our values and expectations are at the heart of everything we do and form an important part of our culture.
    Our values are Patient focus, Transparency, Respect, Integrity.
    Our expectations are Courage, Accountability, Development, Teamwork. Link
    Financials FY 2017: Revenues : INR 2896 crores, Earnings Per Share: INR 41.6, Net Profit: INR 352 crores

    Key People Emma Walmsley [CEO]


    Dr Hal Barron [Chief Scientific Officer and President, R&D]
    Roger Connor [President, Global Manufacturing and Supply]
    GSK India:- D. S. Parekh [Chairman & Non-Executive Director]
    A. Vaidheesh [Managing Director India]

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE


    Business Description
    3 Business
    Areas

    Pharmaceutical Vaccines

    • Manufacturing unit is located at Nashik


    • Clinical development centre is in Bangalore
    • Prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti-
    parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology etc.
    • Range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus
    etc.
    • Company Presence : Global
    • No. Of Employees: Over 4,500

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE


    Company Analysis
    • At GSK, they have an evolving business model for a sustainable future
    • Focused around five strategic priorities
    • Grow a diversified global business
    • Deliver more products of value
    • Simplify the operating model
    • Create a culture of individual empowerment
    • Build trust
    • The company’s research and development (R&D) has collaborations with more than 3,000 external
    organizations worldwide. It has three global R&D hubs - at Rockville, USA; Rixensart, Belgium and Siena, Italy
    • Started construction of its largest Indian tablet manufacturing pharmaceutical factory in Vemgal, Karnataka
    • Builds capacities through dual sourcing for key products
    • The company's future plans include introduction of new strengths for Eltroxin tablets; support Greenfield
    project team to deploy latest technology; continue technical support for India strategy; enhance process
    robustness to minimize the waste; and identify and work on opportunities related to pack redesign,
    configuration, barcoding and serialization
    • The company reported higher cost structure in FY2017 which affected its operating performance

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE


    Product Suite
    Medicines Vaccines

    • Prescription drugs • Around 40% of the world’s children are


    • Prescription Drugs List here immunised against at least one serious
    • Non prescription drugs disease with a GSK vaccine.
    • List of non prescription drugs here • View complete list of vaccines here

    Famous brands include: GSK’s Consumer Healthcare division is being


    sold to HUL.
    • Calpol
    • Augmentin (IV) and Augmentin (ORAL) Major brands of this division include:
    • Ceftum • Horlicks
    • Eno
    • Neosporin EYE Drops
    • Iodex
    • Phexin • Sensodyne
    • Zovirax • Crocin
    • Betnesol etc. • Boost

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE


    Competitors
    • Major competitors of the company in India include:
    • Sun Pharmaceutical Industries Limited
    • Lupin Limited
    • Cipla Ltd.
    • Aarti Drugs Ltd.
    • Ambalal Sarabhai Enterprises Limited
    • Aurobindo Pharma Ltd
    • Bliss GVS Pharma Limited
    • Dr. Reddy's Laboratories Ltd.
    • Morepen Laboratories Limited
    • Ranbaxy Laboratories Limited
    • Solvay Pharma India Ltd., and other

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE


    In News
    • Glaxo to split into two after mega merger deal with Pfizer Link (19 Dec 2018)
    GlaxoSmithKline Plc paved the way for a split into two companies, agreeing to create a consumer-health joint venture with
    Pfizer Inc. that the pharma giants plan to list on the stock market.

    • Merger with GSK will take food and refreshment business to over Rs 10,000 crore, says HUL Link
    (17 Dec 2018)
    In one of the biggest deals across the consumer goods space, Hindustan Unilever (HUL) has bought GSK's India
    business for around $3.8 billion. The deal increases the consumer goods giant's footprint in one of the world's fastest-
    growing economies.

    • Steer Engineering moves Delhi HC against GSK Consumer over Unilever deal Link (9 Dec 2018)
    Bengaluru-based Steer Engineering has moved the Delhi High Court seeking protection of the technology and know-how
    that it provided to GSK Consumer Healthcare in India. The technology is used for the manufacture of food and malt-based
    drinks such as Horlicks and Boost.

    • GlaxoSmithKline to acquire Tesaro to strengthen pharmaceuticals business Link (8 Dec 2018)


    GlaxoSmithKline is buying Tesaro, a company developing drugs for cancer treatment, for approximately $5.1 billion.
    Though it will be 2020 before it increases GlaxoSmithKline’s bottom line, CEO Emma Walsmley cites increased
    capabilities in oncological research and treatment. Having sold its oncology assets in 2015, the acquisition marks a fresh
    start for CEO Walsmley.

    PLACEMENT PREPARATION COMMITTEE, IIM INDORE

    You might also like